View Item 

Show simple item record

Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma
dc.contributor.authorHa Lan, Thanh T.en_US
dc.contributor.authorChen, Stephanie J. T.en_US
dc.contributor.authorArps, David P.en_US
dc.contributor.authorFullen, Douglas R.en_US
dc.contributor.authorPatel, Rajiv M.en_US
dc.contributor.authorSiddiqui, Javeden_US
dc.contributor.authorCarskadon, Shannonen_US
dc.contributor.authorPalanisamy, Nallasivamen_US
dc.contributor.authorHarms, Paul W.en_US
dc.date.accessioned2014-12-09T16:54:04Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-12-09T16:54:04Z
dc.date.issued2014-11en_US
dc.identifier.citationHa Lan, Thanh T.; Chen, Stephanie J. T.; Arps, David P.; Fullen, Douglas R.; Patel, Rajiv M.; Siddiqui, Javed; Carskadon, Shannon; Palanisamy, Nallasivam; Harms, Paul W. (2014). "Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma." Journal of Cutaneous Pathology 41(11): 831-838.en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109645
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAtypical Fibroxanthomaen_US
dc.subject.otherP40en_US
dc.subject.otherP63en_US
dc.subject.otherSquamous Cell Carcinomaen_US
dc.subject.otherDeltaNp63en_US
dc.titleExpression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinomaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109645/1/cup12387.pdf
dc.identifier.doi10.1111/cup.12387en_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceCrum CP, McKeon FD. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5: 349.en_US
dc.identifier.citedreferenceGleason BC, Calder KB, Cibull TL, et al. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma. J Cutan Pathol 2009; 36: 543.en_US
dc.identifier.citedreferenceKanner WA, Brill LB 2nd, Patterson JW and Wick MR. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma. J Cutan Pathol 2010; 37: 744.en_US
dc.identifier.citedreferenceMills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708.en_US
dc.identifier.citedreferenceYang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714.en_US
dc.identifier.citedreferenceWu M, Szporn AH, Zhang D, et al. Cytology applications of p63 and TTF‐1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol 2005; 33: 223.en_US
dc.identifier.citedreferenceKargi A, Gurel D, Tuna B. The diagnostic value of TTF‐1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007; 15: 415.en_US
dc.identifier.citedreferenceTerry J, Leung S, Laskin J, Leslie KO, Gown AM and Ionescu DN. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol 2010; 34: 1805.en_US
dc.identifier.citedreferenceMukhopadhyay S, Katzenstein AL. Subclassification of non‐small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF‐1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011; 35: 15.en_US
dc.identifier.citedreferenceRekhtman N, Ang DC, Sima CS, Travis WD and Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole‐tissue sections with validation in small specimens. Mod Pathol 2011; 24: 1348.en_US
dc.identifier.citedreferenceChilosi M, Zamo A, Brighenti A, et al. Constitutive expression of DeltaN‐p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch 2003; 443: 175.en_US
dc.identifier.citedreferenceHallack Neto AE, Siqueira SA, Dulley FL, Ruiz MA, Chamone DA and Pereira J. p63 protein expression in high risk diffuse large B‐cell lymphoma. J Clin Pathol 2009; 62: 77.en_US
dc.identifier.citedreferenceJo VY, Fletcher CD. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol 2011; 136: 762.en_US
dc.identifier.citedreferenceBishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP and Westra WH. Accurate classification of non‐small cell lung carcinoma using a novel microRNA‐based approach. Clin Cancer Res 2010; 16: 610.en_US
dc.identifier.citedreferencePelosi G, Pasini F, Olsen Stenholm C, et al. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 2002; 198: 100.en_US
dc.identifier.citedreferenceTsuta K, Tanabe Y, Yoshida A, et al. Utility of 10 immunohistochemical markers including novel markers (desmocollin‐3, glypican 3, S100A2, S100A7, and Sox‐2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol 2011; 6: 1190.en_US
dc.identifier.citedreferenceYoshida A, Tsuta K, Watanabe S, et al. Frequent ALK rearrangement and TTF‐1/p63 co‐expression in lung adenocarcinoma with signet‐ring cell component. Lung Cancer 2011; 72: 309.en_US
dc.identifier.citedreferenceDi Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002; 8: 494.en_US
dc.identifier.citedreferenceNylander K, Vojtesek B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002; 198: 417.en_US
dc.identifier.citedreferenceYang A, Kaghad M, Wang Y. p63, a p53 homolog at 3q27‐29, encodes multiple products with transactivating, death‐inducing, and dominant‐negative activities. Mol Cell 1998; 2: 305.en_US
dc.identifier.citedreferenceBishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP and Westra WH. p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012; 25: 405.en_US
dc.identifier.citedreferenceBishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol 2014; 38: 257.en_US
dc.identifier.citedreferencePouryazdanparast P, Yu L, Cutlan JE, Olsen SH, Fullen DR and Ma L. Diagnostic value of CD163 in cutaneous spindle cell lesions. J Cutan Pathol 2009; 36: 859.en_US
dc.identifier.citedreferenceBuonaccorsi JN, Plaza JA. Role of CD10, wide‐spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Am J Dermatopathol 2012; 34: 404.en_US
dc.identifier.citedreferenceHall JM, Saenger JS, Fadare O. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas. Int J Clin Exp Pathol 2008; 1: 524.en_US
dc.identifier.citedreferenceWieland CN, Dyck R, Weenig RH and Comfere NI. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma. J Cutan Pathol 2011; 38: 884.en_US
dc.identifier.citedreferenceLewis JS, Ritter JH, El‐Mofty S. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder‐p63, MOC‐31, and TTF‐1. Mod Pathol 2005; 18: 1471.en_US
dc.identifier.citedreferenceDotto JE, Glusac EJ. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006; 33: 413.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cup12387.pdf
Size:
1.801MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.